Vitamin B12 Injection Dosing
For vitamin B12 deficiency with neurological involvement, administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs, then 1 mg every 2 months; for deficiency without neurological involvement, give hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by maintenance of 1 mg every 2-3 months for life. 1
Initial Assessment: Determine Neurological Involvement
Before initiating treatment, assess for neurological symptoms including:
- Unexplained sensory disturbances
- Motor weakness
- Gait abnormalities
- Peripheral neuropathy
Critical caveat: If neurological involvement is suspected, seek urgent specialist advice from both a neurologist and haematologist while initiating treatment immediately 1. Delaying treatment beyond 3 months can produce permanent degenerative spinal cord lesions 2.
Treatment Algorithm
With Neurological Involvement (Subacute Combined Degeneration Risk)
Loading phase:
- Hydroxocobalamin 1 mg IM on alternate days
- Continue until no further clinical improvement observed
- This typically requires multiple weeks of intensive therapy
Maintenance phase:
- Hydroxocobalamin 1 mg IM every 2 months lifelong 1
Without Neurological Involvement
Loading phase:
- Hydroxocobalamin 1 mg IM three times per week for 2 weeks
- This provides 6 total loading injections 1
Maintenance phase:
- Hydroxocobalamin 1 mg IM every 2-3 months for life 1
Research supports that 6 loading injections are necessary to biochemically correct deficiency, as shorter regimens (3 injections) prove insufficient 3.
Dosing Considerations
Use 1000 mcg (1 mg) doses consistently. The evidence strongly supports this dose over smaller 100 mcg doses, as significantly greater amounts are retained with 1000 mcg injections with no disadvantage in cost or toxicity 4. The FDA label confirms doses up to 1000 mcg are standard 2.
Formulation: Hydroxocobalamin is preferred over cyanocobalamin in guidelines, though cyanocobalamin 1000 mcg is the only preparation available in the United States 4. Both are effective when dosed appropriately.
Critical Safety Warnings
Never administer folic acid before treating B12 deficiency. Folic acid can mask B12 deficiency hematologically while allowing irreversible neurological damage (subacute combined degeneration of the spinal cord) to progress 1, 2. Always check and treat B12 deficiency first.
Monitor serum potassium closely during the first 48 hours of treatment in patients with pernicious anemia, as rapid hematologic response can precipitate hypokalemia requiring replacement 2.
Individualized Frequency Adjustments
While guidelines recommend every 2-3 month maintenance, clinical experience indicates up to 50% of patients require more frequent administration (ranging from every 2-4 weeks) to remain symptom-free 5. Do not titrate injection frequency based on serum B12 or MMA levels—base adjustments on clinical symptom control 5.
Monitoring During Treatment
Initial phase (days 5-7):
- Daily hematocrit and reticulocyte counts
- Continue frequently until hematocrit normalizes 2
Baseline measurements:
- Serum B12, folate, iron studies, ferritin
- Full blood count
- If reticulocytes don't increase or sustain at twice normal levels, reevaluate diagnosis 2
Alternative Routes (Limited Evidence)
Oral B12 (1000-2000 mcg daily) may be as effective as IM for some patients 6, but parenteral administration remains preferred for malabsorption-related deficiency 5. There is insufficient evidence to support oral/sublingual replacement of injections in established deficiency requiring parenteral therapy 5.
Pregnancy considerations: Requirements increase to 5 mcg/day during pregnancy; continue established IM regimens and ensure adequate supplementation 7, 8.